Cargando…
Artificial intelligence in oncology: Path to implementation
In recent years, the field of artificial intelligence (AI) in oncology has grown exponentially. AI solutions have been developed to tackle a variety of cancer‐related challenges. Medical institutions, hospital systems, and technology companies are developing AI tools aimed at supporting clinical dec...
Autores principales: | Chua, Isaac S., Gaziel‐Yablowitz, Michal, Korach, Zfania T., Kehl, Kenneth L., Levitan, Nathan A., Arriaga, Yull E., Jackson, Gretchen P., Bates, David W., Hassett, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209596/ https://www.ncbi.nlm.nih.gov/pubmed/33960708 http://dx.doi.org/10.1002/cam4.3935 |
Ejemplares similares
-
Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor‐infiltrating immune cell analysis
por: Wan, Yi, et al.
Publicado: (2021) -
Development and validation of MRI‐based deep learning models for prediction of microsatellite instability in rectal cancer
por: Zhang, Wei, et al.
Publicado: (2021) -
Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer
por: Arend, Rebecca C., et al.
Publicado: (2021) -
A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma
por: Fan, Yaqi, et al.
Publicado: (2021) -
Construction of circRNA‐based ceRNA network and its prognosis‐associated subnet of clear cell renal cell carcinoma
por: Zhang, Yuwei, et al.
Publicado: (2021)